These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29509918)

  • 1. Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects.
    Samuels MH; Kolobova I; Niederhausen M; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2018 May; 103(5):1997-2008. PubMed ID: 29509918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Altering Levothyroxine Dose on Energy Expenditure and Body Composition in Subjects Treated With LT4.
    Samuels MH; Kolobova I; Niederhausen M; Purnell JQ; Schuff KG
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4163-4175. PubMed ID: 30165520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Thyroid Function Variations Within the Laboratory Reference Range on Health Status, Mood, and Cognition in Levothyroxine-Treated Subjects.
    Samuels MH; Kolobova I; Smeraglio A; Niederhausen M; Janowsky JS; Schuff KG
    Thyroid; 2016 Sep; 26(9):1173-84. PubMed ID: 27338133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.
    Samuels MH; Kolobova I; Smeraglio A; Peters D; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2014 Mar; 99(3):843-51. PubMed ID: 24423358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status, mood, and cognition in experimentally induced subclinical hypothyroidism.
    Samuels MH; Schuff KG; Carlson NE; Carello P; Janowsky JS
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2545-51. PubMed ID: 17473069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
    Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial.
    Walsh JP; Ward LC; Burke V; Bhagat CI; Shiels L; Henley D; Gillett MJ; Gilbert R; Tanner M; Stuckey BG
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2624-30. PubMed ID: 16670161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
    Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
    Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects.
    Samuels MH; Schuff KG; Carlson NE; Carello P; Janowsky JS
    Thyroid; 2007 Mar; 17(3):249-58. PubMed ID: 17381359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
    Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
    Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
    Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
    Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study.
    Parle J; Roberts L; Wilson S; Pattison H; Roalfe A; Haque MS; Heath C; Sheppard M; Franklyn J; Hobbs FD
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3623-32. PubMed ID: 20501682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
    Fallahi P; Ferrari SM; Antonelli A
    Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Function Variation in the Normal Range, Energy Expenditure, and Body Composition in L-T4-Treated Subjects.
    Samuels MH; Kolobova I; Antosik M; Niederhausen M; Purnell JQ; Schuff KG
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2533-2542. PubMed ID: 28460140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
    Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
    Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study.
    Saravanan P; Chau WF; Roberts N; Vedhara K; Greenwood R; Dayan CM
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):577-85. PubMed ID: 12390330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF.
    Busnelli A; Vannucchi G; Paffoni A; Faulisi S; Fugazzola L; Fedele L; Somigliana E
    Eur J Endocrinol; 2015 Oct; 173(4):417-24. PubMed ID: 26139211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.